Schmid A, Leszczak S, Ober I, Karrasch T, Schäffler A
Department of Internal Medicine III, Giessen University Hospital, Germany.
Department of Internal Medicine I, Regensburg University Hospital, Germany.
Exp Clin Endocrinol Diabetes. 2015 Feb;123(2):88-94. doi: 10.1055/s-0034-1395635. Epub 2015 Feb 5.
Regulation of FGF-19 and FGF-21 by oral uptake of lipids and carbohydrates in healthy individuals is poorly characterized.
We investigated the regulation of FGF-19 and FGF-21 in 2 large cohorts of healthy volunteers during oral lipid tolerance test (OLTT; n=100) and oral glucose tolerance test (OGTT; n=100).
100 volunteers underwent OLTT and OGTT in an outpatient setting. Venous blood was drawn at 0 h (fasting) and at 2, 4, and 6 h in OLTT or 1 and 2 h in OGTT. In order to dissect carbohydrate-induced from lipid-induced effects, a special OLTT solution was applied. Subjects were characterized by anthropometric and laboratory parameters. Serum concentrations of FGF-19 and FGF-21 were measured by enzyme-linked immunosorbent assay (ELISA).
Mean FGF-19 levels ranged between 12 and 544 pg/ml with a fasting mean value of 105±81 pg/ml and 118±86 pg/ml in OLTT and OGTT. Mean FGF-21 levels ranged between 4 and 1 393 pg/ml with a fasting mean value of 160±204 pg/ml and 235±288 pg/ml in OLTT and OGTT. There was a significant, positive correlation between FGF-19 and FGF-21 in OLTT (p<0.001, r=0.5) and in OGTT (p=0.011, r=0.4). FGF-21 levels were positively correlated with waist circumference and waist hip-ratio in both cohorts. OGTT had no effect on FGF-19 and FGF-21. In contrast, FGF-19 levels were significantly induced and FGF-21 levels were significantly reduced during OLTT.
OLTT is a physiological inductor of FGF-19 and a repressor of FGF-21 in healthy adults. There is a significant and positive correlation between FGF-19 and FGF-21. Dietary lipids specifically and differentially regulate FGF-19 and FGF-21 whereas dietary carbohydrates have no effect. The present data provide the clinical basis for the postulated negative feedback loop between dietary lipids and postprandial inhibition of hepatic lipogenesis.
健康个体口服脂质和碳水化合物对成纤维细胞生长因子19(FGF - 19)和成纤维细胞生长因子21(FGF - 21)的调节作用目前尚未完全明确。
我们在2个大型健康志愿者队列中,分别进行口服脂质耐量试验(OLTT;n = 100)和口服葡萄糖耐量试验(OGTT;n = 100),研究FGF - 19和FGF - 21的调节情况。
100名志愿者在门诊环境中接受OLTT和OGTT。在OLTT的0小时(空腹)、2小时、4小时和6小时,或OGTT的1小时和2小时采集静脉血。为区分碳水化合物诱导效应和脂质诱导效应,使用了一种特殊的OLTT溶液。通过人体测量和实验室参数对受试者进行特征描述。采用酶联免疫吸附测定(ELISA)法测定血清中FGF - 19和FGF - 21的浓度。
在OLTT和OGTT中,FGF - 19的平均水平在12至544 pg/ml之间,空腹平均值分别为105±81 pg/ml和118±86 pg/ml。FGF - 21的平均水平在4至1393 pg/ml之间,空腹平均值分别为160±204 pg/ml和235±288 pg/ml。在OLTT(p < 0.001,r = 0.5)和OGTT(p = 0.011,r = 0.4)中,FGF - 19与FGF - 21之间存在显著正相关。在两个队列中,FGF - 21水平均与腰围和腰臀比呈正相关。OGTT对FGF - 19和FGF - 21无影响。相反,在OLTT期间,FGF - 19水平显著升高,FGF - 21水平显著降低。
在健康成年人中,OLTT是FGF - 19的生理性诱导剂和FGF - 21的抑制剂。FGF - 19与FGF - 21之间存在显著正相关。膳食脂质对FGF - 19和FGF - 21具有特异性和差异性调节作用,而膳食碳水化合物则无影响。本研究数据为膳食脂质与餐后肝脏脂肪生成抑制之间的假定负反馈环提供了临床依据。